-
-
NECTAR Conference 2020
-
22nd Apr 2021
-
Posted in Courses & Conferences
- Sophie Skidmore, Venkat Pisupati and Shaline Fazal
-
-
NICE recommends Novartis’ Kesimpta®▼ (ofatumumab) for patients living with relapsing remitting multiple sclerosis (RRMS)
-
21st Apr 2021
-
Posted in Industry News
- Industry news from Novartis
-
-
The self-report version and digital format of the COVID-19 Yorkshire Rehabilitation Scale (C19-YRS) for Long COVID or Post-COVID syndrome assessment and monitoring
-
13th Apr 2021
-
Posted in Clinical Review Article,COVID-19 Articles,Rehabilitation Articles
- A self-report version (and digital format) of the C19-YRS tool for completion by patients with Long Covid.
-
-
Stroke scholarships at UCL – 31st May deadline
-
6th Apr 2021
-
Posted in Course & Conference Previews,Industry News
- * New deadline* Apply by 31st May
-
-
PCN-101 (R-ketamine) for depressive disorders
-
2nd Apr 2021
-
Posted in Industry News
- News from Perception Neuroscience and Otsuka Pharmaceutical Co., Ltd
-
-
Novartis receives EU approval for Kesimpta® (ofatumumab), self-administered, targeted B-cell therapy for adult patients with relapsing MS
-
1st Apr 2021
-
Posted in Industry News
- News from Novartis
-
-
Acute Neurology Masterclass
-
29th Mar 2021
-
Posted in Course & Conference Previews
- The Acute Neurology Masterclass aims to provide an overview of the management of common and emergency neurological problems presenting to hospital. The acute neurology...
-
-
Janssen Receives Positive CHMP Opinion for PONVORY™ ▼ (ponesimod) for RRMS
-
29th Mar 2021
-
Posted in Industry News
- News from Janssen Pharmaceuticals
-
-
Sacred Lives. An account of the history, cultural associations and social impact of epilepsy
-
15th Mar 2021
-
Posted in Book Reviews
- Andrew Larner
-
-
From the Editor…
-
11th Mar 2021
-
Posted in Editor's introduction
- An introduction to the latest issue by Co-Editor Todd Hardy
